FiercePharmaAsia—Astellas job cuts, GSK vet’s $260M Chinese startup, Sun’s Zytiga knockoff

Astellas will cut 600 positions in Japan in an R&D and sales reorg; a GSK infectious disease veteran launches wins $260 million to launch a China-focused biotech; Sun Pharma wins an FDA green ligh…
Read the full story: FiercePharma: Pharma